Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104393910> ?p ?o ?g. }
- W2104393910 endingPage "95" @default.
- W2104393910 startingPage "92" @default.
- W2104393910 abstract "Abstract Background Retinol‐binding protein‐4 ( RBP 4), an adipokine considered as an emerging cardiometabolic risk factor, is increased in patients with moderate‐to‐severe psoriasis. Objective In this study, we aimed to establish the effect of anti‐ TNF ‐α therapy on RBP 4 levels in patients with moderate‐to‐severe psoriasis. We also assessed if RBP 4 levels correlate with metabolic syndrome features and disease severity in these patients. Methods Prospective study on a series of consecutive non‐diabetic patients with moderate‐to‐severe psoriasis who completed 6 months of therapy with adalimumab. Patients with kidney disease, hypertension or body mass index ≥ 35 kg/m 2 were excluded. Metabolic and clinical evaluation was performed at the onset of treatment (time 0) and at month 6. Results Twenty‐nine patients were assessed. Statistically significant reduction ( P = 0.0001) of RBP 4 levels was observed after 6 months of therapy ( RBP 4 at time 0: 55.7 ± 21.4 μg/mL, vs. 35.6 ± 29.9 μg/mL at month 6). No significant correlation between basal RBP 4 levels and metabolic syndrome features or disease severity was found. Nevertheless, although RBP 4 levels did not correlate with insulin resistance, a negative and significant correlation between RBP 4 levels obtained after 6 months of adalimumab therapy and other metabolic syndrome features such as abdominal perimeter and body mass index were observed. At that time, a negative and significant correlation between RBP 4 levels and disease activity scores and ultrasensitive CRP levels was also disclosed. Conclusion Our results support an influence of the anti‐ TNF ‐α blockade on RBP 4 serum levels. This finding is of potential relevance due to increased risk of cardiovascular disease in patients with psoriasis." @default.
- W2104393910 created "2016-06-24" @default.
- W2104393910 creator A5002655652 @default.
- W2104393910 creator A5015376204 @default.
- W2104393910 creator A5016922988 @default.
- W2104393910 creator A5031531166 @default.
- W2104393910 creator A5042879643 @default.
- W2104393910 creator A5045799940 @default.
- W2104393910 creator A5046000172 @default.
- W2104393910 creator A5049778476 @default.
- W2104393910 creator A5055675006 @default.
- W2104393910 creator A5063782762 @default.
- W2104393910 creator A5066815343 @default.
- W2104393910 creator A5082655077 @default.
- W2104393910 creator A5090184335 @default.
- W2104393910 date "2015-02-04" @default.
- W2104393910 modified "2023-10-17" @default.
- W2104393910 title "Anti-TNF-α therapy reduces retinol-binding protein 4 serum levels in non-diabetic patients with psoriasis: a 6-month prospective study" @default.
- W2104393910 cites W1967624900 @default.
- W2104393910 cites W1971826306 @default.
- W2104393910 cites W1975162362 @default.
- W2104393910 cites W1979030077 @default.
- W2104393910 cites W1988870963 @default.
- W2104393910 cites W2017198770 @default.
- W2104393910 cites W2019055265 @default.
- W2104393910 cites W2019856799 @default.
- W2104393910 cites W2034765153 @default.
- W2104393910 cites W2065327957 @default.
- W2104393910 cites W2073501077 @default.
- W2104393910 cites W2076953885 @default.
- W2104393910 cites W2092136583 @default.
- W2104393910 cites W2092809707 @default.
- W2104393910 cites W2092983518 @default.
- W2104393910 cites W2098372184 @default.
- W2104393910 cites W2099551866 @default.
- W2104393910 cites W2105477284 @default.
- W2104393910 cites W2113916513 @default.
- W2104393910 cites W2118336146 @default.
- W2104393910 cites W2154960154 @default.
- W2104393910 cites W2165078562 @default.
- W2104393910 cites W4235203172 @default.
- W2104393910 doi "https://doi.org/10.1111/jdv.13005" @default.
- W2104393910 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25650695" @default.
- W2104393910 hasPublicationYear "2015" @default.
- W2104393910 type Work @default.
- W2104393910 sameAs 2104393910 @default.
- W2104393910 citedByCount "22" @default.
- W2104393910 countsByYear W21043939102015 @default.
- W2104393910 countsByYear W21043939102016 @default.
- W2104393910 countsByYear W21043939102017 @default.
- W2104393910 countsByYear W21043939102018 @default.
- W2104393910 countsByYear W21043939102020 @default.
- W2104393910 countsByYear W21043939102021 @default.
- W2104393910 countsByYear W21043939102022 @default.
- W2104393910 countsByYear W21043939102023 @default.
- W2104393910 crossrefType "journal-article" @default.
- W2104393910 hasAuthorship W2104393910A5002655652 @default.
- W2104393910 hasAuthorship W2104393910A5015376204 @default.
- W2104393910 hasAuthorship W2104393910A5016922988 @default.
- W2104393910 hasAuthorship W2104393910A5031531166 @default.
- W2104393910 hasAuthorship W2104393910A5042879643 @default.
- W2104393910 hasAuthorship W2104393910A5045799940 @default.
- W2104393910 hasAuthorship W2104393910A5046000172 @default.
- W2104393910 hasAuthorship W2104393910A5049778476 @default.
- W2104393910 hasAuthorship W2104393910A5055675006 @default.
- W2104393910 hasAuthorship W2104393910A5063782762 @default.
- W2104393910 hasAuthorship W2104393910A5066815343 @default.
- W2104393910 hasAuthorship W2104393910A5082655077 @default.
- W2104393910 hasAuthorship W2104393910A5090184335 @default.
- W2104393910 hasConcept C126322002 @default.
- W2104393910 hasConcept C134018914 @default.
- W2104393910 hasConcept C188816634 @default.
- W2104393910 hasConcept C194832188 @default.
- W2104393910 hasConcept C203014093 @default.
- W2104393910 hasConcept C2776465410 @default.
- W2104393910 hasConcept C2776940978 @default.
- W2104393910 hasConcept C2777011040 @default.
- W2104393910 hasConcept C2777391703 @default.
- W2104393910 hasConcept C2779134260 @default.
- W2104393910 hasConcept C2779306644 @default.
- W2104393910 hasConcept C2779573558 @default.
- W2104393910 hasConcept C2780132546 @default.
- W2104393910 hasConcept C2780221984 @default.
- W2104393910 hasConcept C2780564577 @default.
- W2104393910 hasConcept C2780578515 @default.
- W2104393910 hasConcept C511355011 @default.
- W2104393910 hasConcept C555293320 @default.
- W2104393910 hasConcept C71924100 @default.
- W2104393910 hasConcept C90924648 @default.
- W2104393910 hasConcept C97749175 @default.
- W2104393910 hasConceptScore W2104393910C126322002 @default.
- W2104393910 hasConceptScore W2104393910C134018914 @default.
- W2104393910 hasConceptScore W2104393910C188816634 @default.
- W2104393910 hasConceptScore W2104393910C194832188 @default.
- W2104393910 hasConceptScore W2104393910C203014093 @default.
- W2104393910 hasConceptScore W2104393910C2776465410 @default.
- W2104393910 hasConceptScore W2104393910C2776940978 @default.
- W2104393910 hasConceptScore W2104393910C2777011040 @default.